KRAS and lung cancer: Also, ferrocene derivatives exhibit anti-cancer effects in lung cancer cells harboring oncogenic mutant K-Ras (Domarle et al, 1998; Perez et al, 2015; Arambula et al, 2016; Peter & Aderibigbe, 2019).